Pegylated interferon-alpha in combination with ribavirin currently represents the therapeutic standard for the hepatitis C virus infection. Interferon based therapy may be responsible for many cutaneous side effects. We report a case of drug-induced Sweet's syndrome secondary to hepatitis C antiviral therapy. To our knowledge, this is the first reported case of Sweet's syndrome in association with pegylated interferon-alpha therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-4632.2008.03724.x | DOI Listing |
Publication Analysis
Top Keywords
sweet's syndrome
12
drug-induced sweet's
8
syndrome secondary
8
secondary hepatitis
8
hepatitis antiviral
8
antiviral therapy
8
pegylated interferon-alpha
8
therapy
4
therapy pegylated
4
interferon-alpha combination
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!